ILCC 2022 Conference Coverage

 

ILCC 2022 Conference Coverage
P

ILCC 2022 on The Role of PARP Inhibitors in DNA Damage Response in Lung Cancer

By ILCC 2022 Conference Coverage FEATURING Paul Bunn
By ILCC 2022 Conference Coverage FEATURING Paul Bunn
212 views
August 5, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Videos
18:14

Systemic Therapy for Brain Metastases in NSCLC

ILCC 2022 Conference Coverage

E. Massarelli

943 views
17:29

Neoadjuvant vs. Adjuvant Immunotherapy From the Surgeon's Perspective

ILCC 2022 Conference Coverage

T. Mitsudomi

1.1K views
09:57

ILCC 2022 Mesothelioma: Updates in Systemic Therapy

ILCC 2022 Conference Coverage

P. Baas

250 views
01:21

Lecture Summary - 1L Single Agent Immunotherapy for mNSCLC

ILCC 2022 Conference Coverage

A. Chiang

14 views
14:33

1L Single Agent Immunotherapy for mNSCLC

ILCC 2022 Conference Coverage

A. Chiang

633 views
09:30

ILCC 2022 on The Role of PARP Inhibitors in DNA Damage Response in L…

ILCC 2022 Conference Coverage

P. Bunn

212 views